Open Access

Expanding evidence on SGLT2i: where are we now and what can we expect?

Topic: Treatment
Sponsored by PACE-CME – Supported by an unrestricted educational grant from AstraZeneca

Congress Presentation

About the speaker

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
65 presentations

3 more presentations in this session

The clinical challenges of initiating guideline-recommended therapy in HFrEF.

Speaker: Professor J. McMurray (Glasgow, GB)


Benefits and evolving insights on SGLT2i in the spectrum of LVEF: can we set priorities?

Speaker: Professor C. Lam (Singapore, SG)


Expert panel: What are the implications for our practice?

Speaker: Professor J. McMurray (Glasgow, GB) Professor C. Lam (Singapore, SG) Professor S. Solomon (Boston, US)


Access the full session

When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options

Speakers: Professor S. Solomon, Professor J. McMurray, Professor C. Lam, Professor J. McMurray, Professor C. Lam...

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb